study question: What is the value of a new strategy for preimplantation genetic diagnosis (PGD) of monogenic diseases: blastocyst biopsy, cryopreservation and thawed embryo transfer? summary answer: This strategy is highly effective for PGD of monogenic diseases and merits wide use. what is known already: PGD of monogenic diseases is conventionally performed on 6-to 8-cell embryos with fresh transfer.
Introduction
Preimplantation genetic diagnosis (PGD) offers an alternative for women to carry a fetus unaffected by hereditary diseases. Embryo biopsy at the cleavage stage (6-to 8-cell stage) with retrieval of one or two blastomeres is the most common approach for PGD of monogenic diseases (Harper et al., 2012) . However, the innate dilemma of cleavage-stage biopsy is that it obtains the very limited genetic material and time available for performing analysis. The risks of misdiagnosis may occur in polymerase chain reaction (PCR)-based protocols. Some misdiagnoses with PGD have been reported in the literature (Wilton et al., 2009) .
With extended embryo culture using more complex media or sequential media, increased rates of blastocyst formation (46 -67%) have been achieved (Gardner et al., 1998; Langley et al., 2001) . Retrieval of 5-10 trophectoderm cells from a 100-or 150-cell blastocyst corresponds to a lower proportion of cell loss, 3.3-10%, compared with the removal of one or two blastomeres from a 6-to 8-cell embryo which reduces the cell content by 12.5-33% (De Vos et al., 2009 ). In addition, blastocyst biopsy provides more starting DNA templates which would theoretically lead to improved sensitivity and specificity of PGD. Pregnancies following blastocyst biopsy and fresh transfer for PGD have recently been reported (de Boer et al., 2004; Kokkali et al., 2007; McArthur et al., 2008) . However, blastocyst biopsy has not been widely applied in PGD of monogenic diseases and merits more investigation.
Embryo biopsy, either at the cleavage stage or at the blastocyst stage, followed by fresh embryo transfer is traditionally performed in PGD of monogenic diseases (Daina et al., 2012; Harper et al., 2012) . There are even some interesting reports showing good results of double examinations for mutation analysis and comprehensive aneuploidy screening using various technologies (Obradors et al., 2008 (Obradors et al., , 2009 Handyside et al., 2010; Brezina et al., 2011) . Although some technologies such as real-time PCR had been developed to shorten the time of molecular diagnosis (Hung et al., 2010) , the time allowed for transportation of the specimens to a reference laboratory and performance of genetic analysis is still limited prior to fresh transfer. This shortcoming is especially considerable after blastocyst biopsy. Recently, vitrification has been verified to be efficient for cryopreservation of blastocysts (Liebermann, 2009) . Cryopreservation of biopsied blastocysts would permit appropriate time for genetic diagnosis. Furthermore, cryopreservation of biopsied blastocysts may avoid late ovarian hyperstimulation syndrome (OHSS) as hCG produced from implanted embryos may induce late and prolonged OHSS after fresh transfer in the high ovarian responders (Chang et al., 2011; Chen et al., 2011) . In spite of the inconveniences for women, such as requiring an additional thawing cycle and corresponding additional economic cost, cryopreservation of embryos may have the advantages of avoiding both the risk of OHSS and a possible suboptimal endometrium (Bosch et al., 2010; Huang et al., 2012) .
The value of the strategy of blastocyst biopsy, cryopreservation and thawed embryo transfer for PGD of monogenic diseases remains indefinable and deserves further investigation. Since November 2008, we started this program for PGD of monogenic diseases. In our work, we analyzed this cohort for hormonal data possibly relating to the endometrial environment after ovarian stimulation, diagnostic efficiency and accuracy, survival of biopsied blastocysts after vitrification, rates of implantation and pregnancy and incidence of OHSS, to ascertain the effectiveness of this strategy for PGD. In addition, we compared the results of blastocyst biopsy with vitrification and thawed embryo transfer to conventional blastomere biopsy with fresh transfer over the same period of time in our center.
Materials and Methods

Patients
The couples at risk of transmitting a monogenic disease to their offspring received comprehensive counseling for PGD as an alternative method to prenatal diagnosis by an experienced geneticist. DNA analysis of blood samples from the couples was conducted to determine the mutation sites in the alleles. The procedures of PGD were explained by a gynecologist. Informed consents were obtained from the couples. From November 2008 to January 2012, the couples underwent the program including blastocyst biopsy, vitrification and thawed embryo transfer. All of the cycles were performed by cooperation of the IVF Center and the Department of Medical Genetics of National Taiwan University Hospital. This study was approved by the ethics committee of the institute.
Testing on single lymphocytes
To evaluate the reliability of the protocol of genetic analysis before the PGD cycles, whole genome amplification (WGA) followed by short tandem repeat (STR) detection and mutation analysis with mini-sequencing and real-time PCR were examined on single lymphocytes. Lymphocytes were isolated from 5 ml of un-clotted blood. The collected single cells (5-10) were transferred into PCR tubes containing 2 ml lysis buffer for DNA analysis. After heat inactivation at 658C for 15 min, the specimens were cooled to 48C for storage. Blank controls were also processed under the same conditions to check for the presence of contamination. The amplification efficiency, allele drop-out (ADO) rate and contamination rate were measured.
Whole genome amplification
WGA of DNA samples was performed by multiple displacement amplification (MDA) using the GenomiPhi V2 DNA amplification kit (GE healthcare, Piscataway, NJ, USA). With 9 ml of GenomiPhi sample buffer, the specimens were sequentially heated to 958C for 10 min. The specimens were amplified with 9 ml of reaction buffer and 1 ml of GenomiPhi enzyme mix, and incubated at 308C for 4 h.
Detection of STR markers
Three to four informative STR markers, distributing around the mutated gene, were selected and examined to detect ADO, contamination or linkage analysis. For the examination of selected STR markers, each PCR was performed in a total volume of 25 ml containing 1 ml of the WGA product, 0.12 mM primers, 2.5 mM dNTPs, 0.5 units of AmpliTaq Gold TM enzyme (PE Biosystems, Foster City, CA, USA) and 2.5 ml of GeneAmp 10× buffer II [10 mM Tris-HCl (pH 8.3), 50 mM KCl in 2 mM MgCl 2 ]. PCR was performed in a multi-block system thermocycler (ThermoHybaid, Ashford, UK) using an initial denaturation at 958C for 10 min, followed by 35 cycles consisting of denaturation at 948C for 30 s, annealing at 508C for 45 s and extension at 728C for 45 s and then a final extension step at 728C for 10 min. PCR products were analyzed using the Beckman CEQ-8000 genetic analysis system (Beckman Coulter, Inc., Fullerton, CA, USA). The presence of unexpected STR markers that were different from that of the couple was thought to be due to contamination of the samples.
Mini-sequencing analysis
The WGA product (1 ml) was also examined for mutation of alleles using a mini-sequencing method. PCR amplification was performed with an initial denaturation step at 958C for 10 min. It was followed by 35 cycles consisting of denaturation at 948C for 30 s, annealing at 538C for 30 s and extension at 728C for 30 s. A final extension step was performed at 728C for 10 min, and amplicons were purified by solid-phase extraction. They were bi-directionally sequenced with the Taq DyeDeoxy terminator cycle sequencing kit (PE Biosystems). Sequencing reactions were detected on a PE Biosystems 373A/3100 sequencer.
Real-time PCR and melting curve analysis
The WGA product (1 ml) was further tested for mutation of alleles by real-time PCR using a LightCycler 480 instrument (Roche, Branchburg, NJ, USA) (Hung et al., 2010) . Briefly, both sense and anti-sense primers were used for the detection of the mutation. One probe was labeled with fluorescein at the 3 ′ end (donor) and another probe (acceptor) was labeled with the red fluorophore at the 5 ′ end. The amplification steps were appended with the subsequent melting curve analysis, which was performed by continuous fluorescence monitoring. The data were analyzed using the gene scanning module software (version 1.3, Roche).
Ovarian stimulation and intracytoplasmic sperm injection
Ovarian stimulation was performed using a GnRH antagonist protocol as previously described (Lee et al., 2005) . The cycles were monitored by serial folliculometry and assessment of serum estradiol, progesterone and LH. When the leading follicles had reached a diameter of 18 mm or more with comparable estradiol levels, 250 mg recombinant hCG (Ovidrel, Merck Serono, Darmstadt, Germany) was administered subcutaneously. For patients at risk of OHSS, GnRH agonist (GnRHa), 0.2 mg Decapeptyl (Triptorelin acetate, Ferring Pharmaceuticals, Hoofddorp, Netherlands) was used (Humaidan et al., 2011) . Transvaginal oocyte retrieval was performed 35 h later. ICSI was used to avoid contamination from sperm and cumulus cells. Fertilization was examined 16 -18 h after ICSI and embryo development was evaluated each day.
Blastocyst biopsy and vitrification
Trophectoderm biopsy was performed on the embryos at the blastocyst stage. On Day 3 or 4 after fertilization, a hole was made on the zona pellucida using a non-contact diode laser (Fertilase, Medical Technologies Montreux, Lausanne, Switzerland). The stage of blastocysts suitable for biopsy was not as synchronic as the blastomere biopsy at the 6-to 8-cell embryo stage. Therefore, we performed biopsy on the afternoon of Day 5 and the morning of Day 6. The criteria for blastocyst biopsy were expanding blastocysts with clear trophectoderm and inner cell mass, and the herniated trophectoderm of each embryo was biopsied for 5 -10 cells using the rubbing method. The specimen was washed and transferred to a PCR tube. The wash drop of each specimen served as a blank control. After biopsy, the individual blastocyst with collapsed blastocoele was cryopreserved by vitrification with the Cryotop method (Kitazato Supply Co., Fujinomiya, Japan) (Chen and Yang, 2009 ).
Thawed embryo transfer and follow-up of pregnancy
In the next cycle, we used a natural ovulatory cycle or hormonal replacement treatment to prepare the endometrium (Chen et al., 2004) . The unaffected blastocysts were thawed. The survival of a blastocyst to be transferred was defined as intact trophectoderm cells and intact inner cell mass with re-expanding blastocoele. One or two embryos were transferred to the maternal uterus. Clinical pregnancy was defined as the presence of an intrauterine gestational sac at 5 weeks of gestation by ultrasound. Ongoing pregnancy was interpreted as the presence of fetal growth with heart activity at 20 weeks. Prenatal diagnosis was performed using chorionic villi sampling at 12 weeks of gestation or amniocentesis at 17 weeks to confirm the results of PGD. The procedures and genetic diagnosis were conducted at the Department of Medical Genetics of the institute and the formal reports were obtained 2 -4 weeks later. All of the data were recorded on the medical charts and computerized databases.
Statistics
The parameters of female ages, hormonal data including FSH, LH, estradiol and progesterone, number of oocytes, fertilized oocytes and embryos transferred were presented as the mean + standard deviation. The percentages of blastocyst formation, genotyping success, amplification failure, ADO, survival after vitrification, implantation, clinical pregnancy and ongoing pregnancy were calculated accordingly. The percentages were compared between the groups using the x 2 or Fisher's exact test.
The mean + standard deviations were compared between the groups using the Mann-Whitney test. Differences were considered significant at P , 0.05.
Results
In the study group, 33 couples received 40 cycles of OPU and ICSI for blastocyst biopsy and vitrification. The various single gene diseases, hereditary modes and mutation sites, OPU treatment cycles, genotyping results of lymphocyte pretests and PGD of embryos are shown in Table I . The indications for PGD consisted of nine a-thalassemia, five spinocerebellar ataxia, three Duchenne muscular dystrophy, two congenital deafness, two hemophilia A, two neurofibromatosis, two retinoblastoma, one b-thalassemia, one Marfan's syndrome, one Alzheimer's diseases, one osteogenesis imperfecta, one osteopetrosis, one ornithine transcarbamylase deficiency, one Bardet -Biedl syndrome and one spinal muscular atrophy. These included 15 autosomal recessive diseases, 12 autosomal dominant diseases and 6 X-linked recessive diseases. The genotyping efficiency in the lymphocyte pretests was 91.6% with the rates of amplification failure of 4% and ADO of 4.4%. There was no contamination found. The female ages, hormonal concentrations and oocyte numbers are summarized in Table II . The mean age of females was 34 + 3 years, ranging from 26 to 41. On the day of hCG or GnRHa administration, the mean estradiol level was 3283 + 2075 pg/ml, ranging from 668 to 8650 pg/ml. There were 21 (53%) cycles with estradiol level .3000 pg/ml. The progesterone level was 1.0 + 0.5 ng/ml, ranging from 0.3 to 2.5 ng/ml. The progesterone levels in 10 (25%) cycles were .1.5 ng/ml. The mean number of oocytes retrieval was 17 + 9, ranging from 4 to 43. There were 11 (28%) cycles with the oocyte number .20.
The outcomes of fertilization, blastocyst formation, genotyping, survival after thawing, embryo transfer and pregnancy are summarized in Table III . The mean number of mature oocytes was 14 + 8. After ICSI of 566 mature oocytes, 436 (77%) oocytes were normally fertilized. From this, 272 (62%) developed to blastocysts and were biopsied. The genotyping success rate was 90% (244/272). Regarding the unsuccessful genotypings, incidences of amplification failure (14/272) and ADO (14/272) were both 5%. There was no contamination for any of the 272 reactions. There were no unaffected embryos in six OPU cycles. Frozen-thawed embryo transfer was performed for 38 cycles, although only 34 OPU cycles had available unaffected embryos. The survival rate of blastocysts after thawing was 94% (64/68). The mean number of embryos transferred per transfer The results of the conventional blastomere biopsy at the 6-to 8-cell stage embryos and fresh transfer at the blastocyst stage over the same period are shown in Table IV and were used for comparison. We found that there were no significant differences between the two groups in terms of female age, number of total oocytes, number of mature oocytes or number of normally fertilized oocytes. The percentage of embryos that received blastomere biopsy (78%) was significantly greater than those that underwent trophectoderm biopsy (62%). But, the genotyping success rate of the blastomere biopsy group (71%) was significantly lower than that of the trophectoderm biopsy group (90%). The incidences of amplification failure (13%) or ADO (16%) of the blastomere group were significantly higher than those in the trophectoderm group (5 and 5%, respectively). The mean number of embryos transferred per transfer cycle was not significantly different between the two groups. However, the implantation rate of the blastomere biopsy with fresh transfer (16%) was significantly lower than that of the trophectoderm biopsy with frozen embryo transfer (50%). The ongoing pregnancy rate per OPU cycle of the blastomere group (33%) was significantly lower than that of the trophectoderm group (60%). There was one patient suffering from late OHSS in the group with blastomere biopsy and fresh transfer (6.7%).
Discussion
We verify that blastocyst biopsy, vitrification and thawed embryo transfer are effective for PGD of monogenic diseases. This strategy achieves high rates of genotyping success (90%), survival after warming (94%) and pregnancy (60%). All of the genotyping results of prenatal diagnosis were consistent with PGD without misdiagnosis. For many IVF centers, the distance between the IVF laboratory and the genetic laboratory is remote. Transportation of specimens to the reference laboratory usually takes time. Cryopreservation of biopsied blastocysts allows ample time for both shipment of the sample and performance of genetic analysis, and can facilitate double confirmatory genotypings or repeat examinations for uncertain results (Chen et al., 2008) . In combination with WGA, accurate diagnosis may be achieved while minimizing the level of error. This strategy also permits more flexible time to conduct molecular analysis and embryo transfer during working hours instead of holidays. Recently, there are also published studies using trophectoderm biopsy, vitrification, comprehensive preimplantation genetic screening and frozen embryo transfer (Schoolcraft et al., 2010 (Schoolcraft et al., , 2011 .
In this series, the rates of amplification failure (5%), ADO (5%) and contamination (0%) were low, and adhered to the guidelines set by the European Society of Human Reproduction and Embryology Preimplantation Genetic Diagnosis Consortium (ESHRE PGD Consortium) (Harton et al., 2011) . ADO or contamination could lead to misdiagnosis and decrease the efficiency of PGD (Wilton et al., 2009) . For autosomal dominant diseases, ADO of the abnormal allele of an affected embryo would result in it being diagnosed as a normal embryo. The misdiagnosis would bring about an affected fetus. Similarly, for autosomal recessive diseases, ADO of the normal allele of a carrier embryo would result in it being diagnosed as an affected embryo. As such, the number of embryos available for transfer Basal LH level (mIU/ml) 3.9 + 1.8
Basal estradiol level (pg/ml) 34 + 17
Basal progesterone level (ng/ml) 0.4 + 0.1 LH level on the hCG or GnRHa day (mIU/ml) 2.7 + 2.1
Estradiol level on the hCG or GnRHa day (pg/ml) 3283 + 2075
Progesterone level on the hCG or GnRHa day (ng/ml) 1.0 + 0.5
Number of oocytes retrieved 17 + 9
Data are expressed as the mean + standard deviation.
would be decreased. Multiplex PCR for mutated genes and linked polymorphic markers have been used for detections of mutation, contamination and ADO (Fiorentino et al., 2006; Gutiérrez-Mateo et al., 2009; Harton et al., 2011) . It is critical to design compatible multiple primers and conditions because several PCR reactions may interfere reciprocally in a tube, and the detection procedures of multiplex PCR cannot be repeated when one of the PCR reactions fails. MDA has been recently used for WGA of scanty DNA material with unbiased amplification (Hellani et al., 2005; Glentis et al., 2009) . In this series, we successfully applied MDA on the biopsied sample for WGA and examined the mutated gene as well as the linked STR markers independently and easily. In this study, ADO and amplification failure occurred even though WGA was performed in more than one cell. These terms originally refer to consequences due to errors produced when single-cell DNA is amplified in PGD. But when more than one cell is processed simultaneously, it is more difficult to attribute the responsibility for this absence of result exclusively as a consequence of amplification failure or preferential amplification of the same fragment. When, in the same PGD cycle, cytogenetic analysis is later performed in the embryos, it is possible to see practically all the chromosomes involved in aneuploidy or segmental imbalances. Then the existence of a cytogenetic reason, in which aneuploidies or segmental imbalances involving the chromosome or chromosomal segment in which the mutated gene is placed, would have to be considered in addition to ADO or amplification failure.
In contrast to cleavage-stage biopsy, trophectoderm biopsy provides more cells for genetic analysis, and the accuracy and efficiency are both increased. With fresh embryo transfer, Kokkali et al. (2007) reported a higher genotyping rate (94%) for the blastocyst biopsy group, compared with the cleavage-stage biopsy group (75%). They found that the rates of amplification failure and ADO were 6 and 0% in the former group compared with 10 and 15%, respectively, in the latter group. A smaller percentage of embryos were biopsied and examined in the blastocyst biopsy group (47 versus 77%), because only embryos competently developing to blastocysts were performed. Mainly due to a higher genotyping rate, more unaffected embryos were available for transfer in the blastocyst biopsy group than the cleavage-stage biopsy group. Therefore, blastocyst biopsy would be relatively cost-effective and less labor-intensive.
We compare the data of trophectoderm biopsy to conventional blastomere biopsy over the same period of time at our center. The Figure 1 An example of linkage analysis using STR markers for PGD of a familiar spinocerebellar ataxia type 3 (SCA3) (case number 33) is shown.
The wife (arrow) was affected with SCA3 confirmed by trinucleotides repeat analysis and the husband was unaffected. The couple has an affected child (arrow head) who has also been confirmed by trinucleotides repeats analysis. Four informative STR markers (D14S617, D14S1015, D14S1016 and D14S973) adjacent to ATXN3 gene were used. The sizes of PCR products for STR markers are shown for the couple, the affected child and embryos. The alleles in black and red color indicated wild-type and mutated alleles, respectively. After linkage analysis of the biopsied samples of nine blastocysts, we found that seven affected embryos (1, 5, 7, 8, 9, 11, 15) inherited a mutated allele from the wife and a wild-type allele from the husband while two unaffected embryos (2 and 16) inherited a wild-type allele from the wife and a wild-type allele from the husband. There was no ADO or contamination found.
percentage of embryos undergoing biopsy in the trophectoderm group was significantly less than that of the blastomere group (62 versus 78%). But the genotyping success rate of the trophectoderm group (90%) was significantly higher than that of the blastomere group (71%). The incidences of amplification failure (5%) or ADO (5%) of the trophectoderm group were significantly fewer than those of the blastomere group (13 and 16%, respectively). Our results supported the findings of the report by Kokkali et al. (2007) that blastocyst biopsy increased the success rate of genotyping while reducing the rates of amplification failure and ADO.
OHSS is a potential serious complication of IVF/ICSI cycles, and a critical condition may develop with massive ascites, pleural effusion, hemoconcentration and thrombosis. Vascular endothelial growth factor and interleukin-8 secreted from multiple corpora luteae inducing vascular hyperpermeability may play major roles in the development of OHSS (Chen et al., 2010b) . When the embryo implants, hCG secreted from trophoblasts mediates expression of antiapoptotic protein myeloid cell leukemia-1 of luteal cells that maintains the activities of corpus luteum (Chen et al., 2010a) . A higher estradiol level (.3000 pg/ml) and higher follicle number (.20) are associated Figure 2 An example of mini-sequencing genotyping for PGD of a familial early-onset Alzheimer's disease (case number 30) is shown. The wife (black arrow) was affected with PSEN1 c.438 G.A/WT mutation and the husband was unaffected. The couple had a previous affected abortus (arrow head). Mini-sequencing was performed in PSEN1 gene for the c.438 G.A mutation site. The genotype of wife with the heterozygous PSEN1 mutation showed three peaks with the first peak corresponding to the unextended primers while the second peak and the third peak (red arrow) corresponded to wild-type allele and mutated allele, respectively. The genotype of the husband with homologous wild-type alleles revealed two peaks. After mini-sequencing analysis of the biopsied sample of five blastocysts, we found two affected embryos (3 and 7) with three peaks and three unaffected embryos (1, 4 and 5) with two peaks.
with risk of OHSS (Levinsohn et al., 2003; Chen et al., 2011) . In this series, on the day of hCG or GnRHa administration, the mean estradiol level was 3283 + 2075 pg/ml with 21 (53%) cycles .3000 pg/ml. The mean number of oocytes retrieved was 17 + 9 with 11 (28%) cycles .20. With the GnRH antagonist protocol, we administered GnRH agonist to trigger final oocyte maturation for high responders for the prevention of early OHSS (Humaidan et al., 2011) . Cryopreservation of biopsied embryos without fresh transfer can avoid late OHSS. There was no severe or late OHSS or associated hospitalization in the blastocyst biopsy and vitrification group.
During controlled ovarian stimulation, a subtle rise of serum progesterone before the administration of hCG could occur (Segal et al., 2009; Elnashar, 2010) . This may be due to an increased number of LH receptors and sensitivity of granulosa cells to exogenous gonadotrophin leading to the accumulation of progesterone secretion from multiple follicles (Bosch et al., 2010; Elnashar, 2010) . The dosage of gonadotrophin, estradiol level and the number of follicles are associated with serum progesterone elevation (Venetis et al., 2007; Bosch et al., 2010) . In addition, progesterone receptors of endometrium that could be induced by supraphysiological estradiol levels are significantly up-regulated in stimulated cycles, compared with natural cycles (Papanikolaou et al., 2005) . Prematurely elevated serum progesterone may cause advanced secretory transformation of the endometrium resulting in early closure of the implantation window (Bosch et al., 2010; Labarta et al., 2011) . Recently, the duration of serum progesterone elevation before hCG administration was demonstrated to affect the outcome of IVF/ICSI cycles (Huang et al., 2012) . In this series, we found that on the day of hCG or GnRHa administration, the mean Figure 3 An example of real-time PCR analysis for PGD of a familiar neurofibromatosis type 1 (NF1) (case number 2) was shown. The wife (large arrow) was affected with NF1 gene c.6709C.T/WT mutation and the husband was unaffected. Melting curve analysis of real-time PCR with fluorescence resonance energy transfer hybridization is shown. The gray line and the blue line indicate the genotypes of wife and husband, respectively. The genotype of the wife with the heterozygous c.6709C.T mutation of NF1 gene showed one melting peak at 60.5 o C from the wild-type allele and an additional melting peak (small arrow) at 66 o C from the mutated allele. The genotype of the husband with the homozygous wild-type NF1 gene revealed only one melting peak at 60.5 o C. The green line indicated the genotype of each embryo. Among the 12 blastocysts examined, we found 3 affected embryos (3, 4 and 10) with 1 peak plus an additional peak (arrow head) as well as 9 unaffected embryos (1, 2, 6, 7, 9, 12, 13, 14 and 16) with only 1 peak.
progesterone level was 1.0 + 0.5 ng/ml with 10 (25%) cycles .1.5 ng/ml. Cryopreservation of biopsied blastocysts may circumvent the consequently compromised endometrium.
To study the effect of cryopreservation on the avoidance of suboptimal endometrium, we compared the results of the blastocyst biopsy with cryopreservation and thawing transfer group to a control group with conventional blastomere biopsy and fresh embryo transfer at the blastocyst stage. There were no significant differences in terms of age or number of oocytes retrieved. Also the mean number of embryos transferred per transfer cycle was not significantly different between the two groups. However, the implantation rate and the ongoing pregnancy/live birth rate per transfer cycle of the cryopreservation-thawing group (50 and 63%) were significantly higher than that of the fresh transfer group (16 and 33%). These data could suggest that cryopreservation of biopsied embryos without fresh transfer may avoid a suboptimal endometrium in the cycle with ovarian stimulation. A better receptivity of the unstimulated endometrium may contribute to the higher implantation rate in the thawing cycle.
Conclusions
Blastocyst biopsy, vitrification and thawed embryo transfer are highly effective for PGD of monogenic diseases and deserve wide usage. Cryopreservation of blastocysts after biopsy permits sufficient time for transportation of specimens and molecular diagnosis. In particular, cryopreservation of biopsied embryos without fresh transfer is an important strategy to prevent OHSS and circumvent a suboptimal endometrium in high responders. 
